Lundbeck
HLUN-B.CO
#2597
Rank
โ‚น461.48 B
Marketcap
โ‚น482.43
Share price
0.66%
Change (1 day)
19.20%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is โ‚น30.62. In 2022 the company made an earnings per share (EPS) of โ‚น23.28 a decrease over its 2021 EPS that were of โ‚น52.29.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0124.6%
2022โ‚น23.28-55.47%
2021โ‚น52.29-51.83%
2020โ‚น108.54-28.01%
2019โ‚น150.77-44.08%
2018โ‚น269.6251.94%
2017โ‚น177.45126.64%
2016โ‚น78.29-120.84%
2015-โ‚น375.725622.18%
2014-โ‚น6.57-110.03%
2013โ‚น65.44-28.08%
2012โ‚น90.99-52.1%
2011โ‚น189.95-1.31%
2010โ‚น192.4815.61%
2009โ‚น166.49